Top compounds associated with response to RP11-146B14.1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.095 0.02
mRNA manumycin A CTRPv2 pan-cancer AAC 0.085 0.02
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.079 0.02
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.095 0.02
mRNA piperlongumine CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.088 0.02
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.088 0.02
mRNA FK866 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA parbendazole CTRPv2 pan-cancer AAC 0.08 0.02
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.081 0.02
Download CSV